Pharma Companies Bets as Safer | India’s Pharmaceutical Sector

📖 The Scoop

Why include the Pharma industries stock in your portfolio?

Market participants seeking portfolio diversification may want to consider pharmaceutical stocks. Despite a high-risk reputation, pharmaceutical companies can be compelling for long-term investors. In addition, with the possibility of patented entry into new treatment areas, the industry can present profitable opportunities for those who do their research.

When is the best time to put money into the pharma industry?

When investing in public pharma companies, investors should keep a close watch when they reach the clinical trial stage. Clinical trials are often a make-or-break chance for companies and their products — successful results can lead to significant gains in the market. Still, failures or lack of advancement can have the opposite effect.

How are pharma companies regulated?

The Central Drug Standards Control Organization & US Food and Drug Administration is the regulatory agency behind all medicines that get approved for commercial availability.

Before selling these products, drug companies remain required by the FDA to test them. Several approval processes take place, including analyzing the disease the drug is targeting, looking at other treatment options, reviewing positives and negatives from clinical trials, and examining how to manage any risks associated with the product. However, FDA approval in the healthcare sector can take years. 

Al Zayd Corp

www.alzaydcorp.com

Islamic Finance Research

www.ifr.world

Self-Published Research Magazine

Author: Zayd Iqbal Haji

Copyright © 2020 Al Zayd Corp | Islamic Finance Research

All Rights Reserved.

Disclaimer: 

This investment research report is not an acquisition recommendation and is not misinterpreted for investment consultation as it is a piece of information about the above company. All design content is copyrighted, and references are from the company's annual and RBI reports.

Note: 

Analysts certify that all views expressed in the magazine accurately reflect the theories from the company's annual reports. Moreover, not a part of the investment recommendation or will not be directly or indirectly related to specific recommendations or views expressed in this report. 

Genre: Business & Economics / Accounting / Financial (fancy, right?)